Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer

There is still a great unmet medical need concerning diagnosis and treatment of breast cancer which could be addressed by utilizing specific molecular targets. Tumor-associated MUC1 is expressed on over 90 % of all breast cancer entities and differs strongly from its physiological form on epithelial...

Descripción completa

Detalles Bibliográficos
Autores principales: Stergiou, Natascha, Nagel, Johannes, Pektor, Stefanie, Heimes, Anne-Sophie, Jäkel, Jörg, Brenner, Walburgis, Schmidt, Marcus, Miederer, Matthias, Kunz, Horst, Roesch, Frank, Schmitt, Edgar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775261/
https://www.ncbi.nlm.nih.gov/pubmed/31588183
http://dx.doi.org/10.7150/ijms.35452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775261/
https://www.ncbi.nlm.nih.gov/pubmed/31588183
http://dx.doi.org/10.7150/ijms.35452

Ejemplares similares